- Home
- FNWD vs SAVA Comparison
FNWD vs SAVA Comparison
Compare FNWD & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- SAVA
- Stock Information
- Founded
- FNWD 1994
- SAVA 1998
- Country
- FNWD United States
- SAVA United States
- Employees
- FNWD N/A
- SAVA N/A
- Industry
- FNWD Savings Institutions
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- FNWD Finance
- SAVA Health Care
- Exchange
- FNWD Nasdaq
- SAVA Nasdaq
- Market Cap
- FNWD 117.3M
- SAVA 132.3M
- IPO Year
- FNWD N/A
- SAVA N/A
- Fundamental
- Price
- FNWD $26.97
- SAVA $2.62
- Analyst Decision
- FNWD
- SAVA Buy
- Analyst Count
- FNWD 0
- SAVA 3
- Target Price
- FNWD N/A
- SAVA $111.50
- AVG Volume (30 Days)
- FNWD 3.0K
- SAVA 3.3M
- Earning Date
- FNWD 01-28-2025
- SAVA 02-26-2025
- Dividend Yield
- FNWD 1.78%
- SAVA N/A
- EPS Growth
- FNWD 7.22
- SAVA N/A
- EPS
- FNWD 2.71
- SAVA N/A
- Revenue
- FNWD $69,627,000.00
- SAVA N/A
- Revenue This Year
- FNWD N/A
- SAVA N/A
- Revenue Next Year
- FNWD $1.04
- SAVA N/A
- P/E Ratio
- FNWD $9.97
- SAVA N/A
- Revenue Growth
- FNWD 3.96
- SAVA N/A
- 52 Week Low
- FNWD $22.82
- SAVA $2.23
- 52 Week High
- FNWD $33.50
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- FNWD 32.20
- SAVA 29.65
- Support Level
- FNWD $27.02
- SAVA $2.65
- Resistance Level
- FNWD $27.81
- SAVA $2.78
- Average True Range (ATR)
- FNWD 0.50
- SAVA 0.24
- MACD
- FNWD -0.08
- SAVA 0.55
- Stochastic Oscillator
- FNWD 2.99
- SAVA 38.46
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.